Ensifentrine

Pipeline Prospector July 2025: Merck to acquire Verona for US$ 10 bn; FDA okays Regeneron’s blood cancer med

In July, the pharmaceutical industry witnessed several deals and mergers and acquisitions (M&As). Bi

Pipeline Prospector June 2024: FDA approves Merck’s next-gen pneumococcal vaccine, Verona’s COPD therapy

The pharma indices were back in the black in May, and the good streak continued through June with th